HDAC7 and acute lymphoblastic leukemia: As the basal expression of HDAC7 was comparable between primary t(4;11) pro-B-ALL cells and cell lines, we used the SEM-K2 cells in an in vivo model to determine whether restoring HDAC7 mitigates leukemogenic potential and improves survival.